Intuit (INTU)ive Surgical has announced that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use in Europe for minimally invasive endoscopic procedures across abdominopelvic surgical procedures, including urologic, gynecologic and general laparoscopic surgical procedures, and thoracoscopic surgical procedures. Da Vinci 5 is Intuitive’s most advanced and integrated multiport robotic-assisted surgical system, building on the da Vinci Xi Surgical System’s highly functional design. “We are pleased that our da Vinci 5 Surgical System has received CE mark approval, marking its entry to Europe,” said Intuitive Chief Executive Officer Dave Rosa. “At Intuitive, we’re focused on providing healthcare systems across Europe and around the world with thoughtful innovation that solves problems today and into the future. After over a decade of careful development, da Vinci 5 is the most advanced and integrated platform we’ve ever created – designed to enable better outcomes, efficiency, and insights for the future of minimally invasive care,” said Rosa.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTU:
- Intuit initiated with an Outperform at CLSA
- Intuit’s Strong Growth Potential Driven by Strategic Initiatives and Market-Leading Platforms
- Intuit Announces Leadership Transition in People & Places
- Intuit price target raised to $880 from $825 at Wells Fargo
- Intuit’s Strategic AI Advancements and Monetization Drive Buy Rating